Jean‐Jacques Parienti

198 papers receiving 7.2k citations

Jean‐Jacques Parienti's Hit Papers

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial 2015 · 758 citations
7580+3+7Years since publication250500750

Peers

Jean‐Jacques Parienti
Comparison fields: 5 of 147
  • Emergency Medical Services 1.0k
  • Applied Microbiology and Biotechnology 168
  • Critical Care and Intensive Care Medicine 402
  • Emergency Medicine 702
  • Nephrology 560
Replace Luregn Jan Schlapbach with:
Luregn Jan Schlapbach Switzerland
David T. Huang United States
John Charles O’Horo United States
Fabrice Bruneel France
Mark A. Malangoni United States
T. van der Poll Netherlands
Mark W. Hall United States
Frank A Shann Australia
Brit Long United States
Jean‐Paul Mira France
Jean‐Jacques Parienti relative to Luregn Jan Schlapbach Switzerland Luregn Jan Schlapbach's profile →
Citations per field
00.5×2×4×6.2×
Luregn Jan Schlapbach · 1×
Citations per year

Countries citing papers authored by Jean‐Jacques Parienti

Since Specialization
Citations

This map shows the geographic impact of Jean‐Jacques Parienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Parienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Parienti more than expected).

Fields of papers citing papers by Jean‐Jacques Parienti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Jacques Parienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Parienti. The network helps show where Jean‐Jacques Parienti may publish in the future.

Co-authors

The 25 scholars most cited alongside Jean‐Jacques Parienti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean‐Jacques Parienti Line = papers co-authored together Jean‐Jacques Parienti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
2015758
2
Intravascular Complications of Central Venous Catheterization by Insertion Site
Hit paper breakdown →
2015525
3 2016311
4 2008291
5 2009200
6 2004197
7 2008173
8 2018171
9 2005153
10 2011151
11 2020148
12 2012137
13 2006134
14 2010107
15 2018107
16 201595
17 201192
18 201690
19 200888
20 201188

About Jean‐Jacques Parienti

Jean‐Jacques Parienti is a scholar working on Emergency Medical Services, Infectious Diseases, Virology, Emergency Medicine and Nephrology, having authored 210 papers that have together received 7.5k indexed citations. Recurring topics across this work include Central Venous Catheters and Hemodialysis (24 papers), HIV/AIDS drug development and treatment (22 papers), HIV/AIDS Research and Interventions (16 papers), HIV Research and Treatment (15 papers), Vasculitis and related conditions (10 papers), Sepsis Diagnosis and Treatment (10 papers), Cardiac Arrest and Resuscitation (9 papers) and HIV-related health complications and treatments (7 papers). The work is most often cited by research in Emergency Medical Services (1.0k citations), Applied Microbiology and Biotechnology (168 citations), Critical Care and Intensive Care Medicine (402 citations), Emergency Medicine (702 citations) and Nephrology (560 citations). Jean‐Jacques Parienti has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Damien du Cheyron, Renaud Verdon, Michel Ramakers, Cédric Daubin, Pierre Charbonneau, David R. Bangsberg, Bruno Mégarbane, S. Dargère, Jean‐Paul Mira and Xavier Valette. Their work appears in journals such as Intensive Care Medicine, Clinical Infectious Diseases, Critical Care Medicine, Journal of Antimicrobial Chemotherapy and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact